Literature DB >> 7642524

Differential roles of de novo sphingolipid biosynthesis and turnover in the "burst" of free sphingosine and sphinganine, and their 1-phosphates and N-acyl-derivatives, that occurs upon changing the medium of cells in culture.

E R Smith1, A H Merrill.   

Abstract

Long-chain (sphingoid) bases are highly bioactive intermediates for sphingolipid metabolism, yet relatively little is known about how the amounts of these compounds are regulated. This study used J774A.1 cells to characterize the "burst" of sphinganine and sphingosine, or the transient increase of up to 10-fold in long-chain base mass, that occurs when cells in culture are changed to fresh medium. The increase in sphinganine was attributable to de novo sphingolipid biosynthesis because: 1) there is increased incorporation of [3H]serine and [3H]palmitate into sphinganine; 2) the incorporation of [3H]serine was equivalent to the increase in sphinganine mass; 3) beta-F-alanine, an inhibitor of serine palmitoyltransferase, blocked the sphinganine burst; 4) the magnitude of the burst depended on the concentration of serine in the medium, which is known to affect long-chain base biosynthesis; and 5) the appearance of sphinganine was relatively unaffected by lyso-osmotrophic agents (NH4Cl and chloroquine) that blocked sphingolipid hydrolysis in these cells. In contrast, the sphingosine burst arose mainly from turnover of complex sphingolipids because no incorporation of [3H]serine or [3H]palmitate into sphingosine was detected; sphingosine mass was not affected by beta-F-alanine or the serine concentration; and, the burst could be followed by the release of sphingosine and ceramide from complex sphingolipids (especially sphingomyelin) in a process that was inhibited by NH4Cl and chloroquine. Additionally, the fate of these long-chain bases differed: sphinganine was mostly (80-85%) acylated and incorporated into dihydroceramide and complex sphingolipids, whereas most of the sphingosine (70%) was phosphorylated and degraded, with incorporation of the resulting ethanolamine phosphate into phosphatidylethanolamine. Sphinganine, however, could be diverted toward degradation by adding an inhibitor of N-acylation (fumonisin B1). In accounting for the elevation in sphingosine and sphinganine after cells are changed to new medium, these studies have provided fundamental information about long-chain base metabolism. The existence of differential changes in sphinganine and sphingosine, as well as their 1-phosphates and N-acyl-derivatives, should be considered when evaluating the roles of sphingolipid metabolites in cell regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642524     DOI: 10.1074/jbc.270.32.18749

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Predominance of the acylation route in the metabolic processing of exogenous sphingosine in neural and extraneural cells in culture.

Authors:  L Riboni; R Bassi; A Prinetti; P Viani; G Tettamanti
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

2.  Phospholipid scramblase-3 regulates cardiolipin de novo biosynthesis and its resynthesis in growing HeLa cells.

Authors:  Quyen Van; Jihua Liu; Biao Lu; Kenneth R Feingold; Yuguang Shi; Ray M Lee; Grant M Hatch
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

Review 3.  Ceramide synthases at the centre of sphingolipid metabolism and biology.

Authors:  Thomas D Mullen; Yusuf A Hannun; Lina M Obeid
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

Review 4.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

Review 5.  Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.

Authors:  L G Baggetto
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

6.  Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M.

Authors:  J Y Lee; L G Leonhardt; L M Obeid
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

Review 7.  Thematic review series: sphingolipids. New insights into sphingolipid metabolism and function in budding yeast.

Authors:  Robert C Dickson
Journal:  J Lipid Res       Date:  2008-02-23       Impact factor: 5.922

8.  Involvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formation.

Authors:  Kazuyuki Kitatani; Kely Sheldon; Vinodh Rajagopalan; Viviana Anelli; Russell W Jenkins; Ying Sun; Gregory A Grabowski; Lina M Obeid; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

9.  Diacylglycerol generated during sphingomyelin synthesis is involved in protein kinase C activation and cell proliferation in Madin-Darby canine kidney cells.

Authors:  Jorge Cerbón; Rosa del Carmen López-Sánchez
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

10.  Modulation of sphingolipid metabolism by the phosphatidylinositol-4-phosphate phosphatase Sac1p through regulation of phosphatidylinositol in Saccharomyces cerevisiae.

Authors:  Sarah E Brice; Charlene W Alford; L Ashley Cowart
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.